Skip to main content
Erschienen in:

06.05.2023 | Commentary

How should we prepare a generation of radiologists for MRI-based prostate cancer screening?

verfasst von: Philippe Puech, Patricia Andrea Gutierrez, Vibeke Berg-Løgager, Geert Villeirs

Erschienen in: European Radiology | Ausgabe 10/2023

Einloggen, um Zugang zu erhalten

Excerpt

In 2012, the European Society of Urogenital Radiology (ESUR) released a foundational paper on how to perform, interpret, and report prostate MRI, with the introduction of Prostate Imagining Reporting and Data System (PI-RADS) [1]. This was a significant step forward in the quality assurance and standardisation of practices, and provided a stable reference for training radiologists [2]. Since then, the use of prostate MRI in prostate cancer (PCa) management has continued to expand, encompassing early diagnosis, active surveillance, focal therapy, and recurrence detection. Prostate MRI became widely adopted by the urology community and in 2019 it was endorsed by the European Association of Urology, prior to initial prostate biopsy [3]. The current impact of MRI on patient management is such that urologists, oncologists, and radiation therapists can no longer do without it, and start to consider its potential for PCa screening [4, 5]. In 2022, the European Commission issued a resolution, recommending stepwise but extended screening policies for various cancers, including PCa, which explicitly integrates MRI [6]. At the same time, Hugosson et al showed that including MR data in the algorithm of PCa screening in a large prospective population can reduce the risk of overdiagnosis by half, at the cost of delaying detection of intermediate-risk tumours in a small proportion of patients [5]. These elements point out that prostate MRI may soon become decisive for PCa screening, and reinforce the importance of qualification, certification, and accreditation of radiologists or imaging centres performing prostate MRI [7]. …
Literatur
2.
Zurück zum Zitat Puech P, Randazzo M, Ouzzane A et al (2015) How are we going to train a generation of radiologists (and urologists) to read prostate MRI&quest. Curr Opin Urol 25(6):522–535CrossRefPubMed Puech P, Randazzo M, Ouzzane A et al (2015) How are we going to train a generation of radiologists (and urologists) to read prostate MRI&quest. Curr Opin Urol 25(6):522–535CrossRefPubMed
3.
Zurück zum Zitat Lam TBL, MacLennan S, Willemse PPM et al (2019) EAU-EANM-ESTRO-ESURSIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study). Eur Urol 76(6):790–813 Lam TBL, MacLennan S, Willemse PPM et al (2019) EAU-EANM-ESTRO-ESURSIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study). Eur Urol 76(6):790–813
4.
5.
Zurück zum Zitat Hugosson J, Månsson M, Wallström J et al (2022) Prostate cancer screening with PSA and MRI followed by targeted biopsy only. New Engl J Med 387(23):2126–2137CrossRefPubMed Hugosson J, Månsson M, Wallström J et al (2022) Prostate cancer screening with PSA and MRI followed by targeted biopsy only. New Engl J Med 387(23):2126–2137CrossRefPubMed
6.
Zurück zum Zitat Válek V (2022) Council recommendation of 9 December 2022 on strengthening prevention through early detection: a new EU approach on cancer screening. Off J Eur Union. C473:01 Válek V (2022) Council recommendation of 9 December 2022 on strengthening prevention through early detection: a new EU approach on cancer screening. Off J Eur Union. C473:01
7.
Zurück zum Zitat Lin Y, Yilmaz EC, Belue MJ, Turkbey B (2023) Prostate MRI and image quality: it is time to take stock. Eur J Radiol 161:110757CrossRefPubMed Lin Y, Yilmaz EC, Belue MJ, Turkbey B (2023) Prostate MRI and image quality: it is time to take stock. Eur J Radiol 161:110757CrossRefPubMed
8.
Zurück zum Zitat de Rooij M, Israël B, Tummers M et al (2020) ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists’ training. Eur Radiol 30(10):5404–5416CrossRefPubMedPubMedCentral de Rooij M, Israël B, Tummers M et al (2020) ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists’ training. Eur Radiol 30(10):5404–5416CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Barrett T, Ghafoor S, Gupta RT et al (2022) Prostate MRI qualification: AJR Expert Panel narrative review. AJR Am J Roentgenol 219(5):691–702CrossRefPubMed Barrett T, Ghafoor S, Gupta RT et al (2022) Prostate MRI qualification: AJR Expert Panel narrative review. AJR Am J Roentgenol 219(5):691–702CrossRefPubMed
12.
Zurück zum Zitat Peters M, Eldred-Evans D, Kurver P et al (2022) Predicting the need for biopsy to detect clinically significant prostate cancer in patients with a magnetic resonance imaging–detected prostate imaging reporting and data system/Likert ≥3 lesion: development and multinational external validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score. Eur Urol 82(5):559–568CrossRefPubMed Peters M, Eldred-Evans D, Kurver P et al (2022) Predicting the need for biopsy to detect clinically significant prostate cancer in patients with a magnetic resonance imaging–detected prostate imaging reporting and data system/Likert ≥3 lesion: development and multinational external validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score. Eur Urol 82(5):559–568CrossRefPubMed
Metadaten
Titel
How should we prepare a generation of radiologists for MRI-based prostate cancer screening?
verfasst von
Philippe Puech
Patricia Andrea Gutierrez
Vibeke Berg-Løgager
Geert Villeirs
Publikationsdatum
06.05.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 10/2023
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-023-09680-3

Neu im Fachgebiet Radiologie

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

Abdominale CT bei Kindern: 40% mit Zufallsbefunden

Wird bei Kindern mit stumpfem Trauma eine CT des Bauchraums veranlasst, sind in rund 40% der Fälle Auffälligkeiten zu sehen, die nichts mit dem Trauma zu tun haben. Die allerwenigsten davon sind klinisch relevant.

Genügt die biparametrische MRT für die Prostatadiagnostik?

Die multiparametrische Magnetresonanztomografie hat einen festen Platz im Screening auf klinisch signifikante Prostatakarzinome. Ob auch ein biparametrisches Vorgehen ausreicht, ist in einer Metaanalyse untersucht worden.

Höhere Trefferquoten bei Brustkrebsscreening dank KI?

Künstliche Intelligenz unterstützt bei der Auswertung von Mammografie-Screenings und senkt somit den radiologischen Arbeitsaufwand. Wie wirken sich diese Technologien auf die Trefferquote und die Falsch-positiv-Rate aus? Das hat jetzt eine Studie aus Schweden untersucht.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.